The progression of atherosclerosis in people who have no symptoms of it is independently associated with the risk of dying from any cause, according to a new study led by researchers from Mount Sinai ...
Heart disease remains a leading cause of death globally, and simple lifestyle changes, such as avoiding smoking and managing stress, can make a significant difference in heart health. Efforts like ...
In an online poll conducted by Wockhardt Hospitals, Mira Road, with a sample size of 547 inclusive of both males and females ...
Mount Sinai study also shows imaging for early detection and monitoring can improve prediction and prevention of premature ...
GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in ...
The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.
A study carried out at Mount Sinaí Fuster Heart Hospital in New York in collaboration with the Centro Nacional de ...
The Brighterside of News on MSN22h
Game changing new discovery could prevent heart disease, study findsIn the continuous quest for medical breakthroughs, an international consortium of scientists made a groundbreaking discovery ...
Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback